Singapore markets open in 4 hours 50 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.74+0.14 (+1.21%)
At close: 4:00PM EDT

11.75 +0.01 (0.09%)
After hours: 4:01PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 51.97B
Enterprise value 31.67B
Trailing P/E N/A
Forward P/E 1-24.98
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)717.56
Price/book (mrq)10.01
Enterprise value/revenue 3610.29
Enterprise value/EBITDA 6-15.67

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 3457.69%
S&P500 52-week change 315.54%
52-week high 333.79
52-week low 32.00
50-day moving average 313.27
200-day moving average 314.68

Share statistics

Avg vol (3-month) 325.93M
Avg vol (10-day) 326.54M
Shares outstanding 5167.52M
Float 164.19M
% held by insiders 12.69%
% held by institutions 129.41%
Shares short (14 Sep 2020) 457.22M
Short ratio (14 Sep 2020) 43.94
Short % of float (14 Sep 2020) 434.87%
Short % of shares outstanding (14 Sep 2020) 434.16%
Shares short (prior month 13 Aug 2020) 447.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 305 Jun 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,045.74%

Management effectiveness

Return on assets (ttm)-22.79%
Return on equity (ttm)-184.48%

Income statement

Revenue (ttm)2.74M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)96.90%
Gross profit (ttm)-82.01M
EBITDA -106.74M
Net income avi to common (ttm)-222M
Diluted EPS (ttm)-1.85
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)371.66M
Total cash per share (mrq)2.22
Total debt (mrq)101.02M
Total debt/equity (mrq)54.21
Current ratio (mrq)10.06
Book value per share (mrq)1.17

Cash flow statement

Operating cash flow (ttm)-94.08M
Levered free cash flow (ttm)-51.83M